Epidemiology of enterococci in a neonatal intensive care unit

Infection Control and Hospital Epidemiology

Volumn 29, Issue 4, 2008, Pages 374-376

  Duchon, Jennifer ^a   Graham III, Philip ^a,b   Della Latta, Phyllis ^a   Whittier, Susan ^a   Carp, Diane ^a,b   Bateman, David ^a   Saiman, Lisa ^a,b,c  

^a Columbia University ^*

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c PH4W 470 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; VANCOMYCIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NEWBORN; NEWBORN INTENSIVE CARE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CASE-CONTROL STUDIES; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FECES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LOGISTIC MODELS; NEW YORK CITY; RECTUM; RISK FACTORS; SENTINEL SURVEILLANCE; VANCOMYCIN RESISTANCE;

EID: 40949106533     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/533544     Document Type: Article

References (12)

1. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in regional neonatal intensive care unit. Pediatr Infect Dis J 1999; 18:352-356.
2. McNeely DF, Saint-Louis F, Noel GJ. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr Infect Dis J 1996; 15:800-805.
3. Furtado GH, Mendes RE, Pignatari ACC, Wey SB, Medeiros EAS. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006; 34:447-451.
4. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001; 135:175-183.
5. Huh JY, Lee WG, Jin HY. Molecular characterization of vancomycin-resistant enterococci from clinical and surveillance specimens. Infect Control Hosp Epidemiol 2006; 27:1076-1080.
6. Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Wayne, PA: Clinical Laboratory and Standards Institute; 2006:M100-S16.
7. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
8. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005; 147:156-161.
9. Rupp ME, Marion N, Fey PD, et al. Outbreak of vancomycin- resistant Enterococcus faecium in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2001; 22:301-303.
10. Golan Y, Doron S, Sullivan B, Snydman DR. Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24:566-567.
11. Singh N, Léger MM, Campbell J, Short B, Campos JM. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2005; 26:646-649.
12. Cook H, Cimiotti J, Della-Latta P, et al. Antimicrobial resistance patterns of colonizing flora on nurses' hands in the neonatal intensive care unit. Am J Infect Control 2007; 35:231-236.